EXHIBIT 1
AGREEMENT
In accordance with Rule 13d-1(k)(1) under the Securities
Exchange Act of 1934, as amended, the undersigned hereby agree that this
Statement on Schedule 13D relating to the Common Stock, $0.01 par value, of
Biocryst Pharmaceuticals, Inc. is being filed with the Securities and Exchange
Commission on behalf of each of them.
October 13, 2005
By: /s/ Xxxxxx X. Xxxxx
------------------------------
Xxxxxx X. Xxxxx
By: /s/ Xxxxx X. Xxxxx
------------------------------
Xxxxx X. Xxxxx
Page 8 of 8
